SightfileU.S. market data from official filings

Companies › ALGS

Aligos Therapeutics Inc (ALGS)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001799448 · EDGAR filings · Updated 2026-06-29

Aligos Therapeutics Inc (ALGS) has reported institutional ownership of 44.8%, with 34 institutional managers holding positions valued at $20.6M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
44.8%
Institutional managers
34
Reported 13F value
$20.6M
Data flags
2 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Aligos Therapeutics Inc has 34 institutional holders and institutional ownership of 44.8%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 0 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-07 (recurring since 2025-11-06) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2024-05-31 (recurring since 2023-09-07) — source filing. The authoritative details are those stated in the filing itself.

Related companies

Black Hawk Acquisition Corp (BKHA) · ACRIVON THERAPEUTICS INC (ACRV) · ALPHA TEKNOVA INC (TKNO) · BIOTE CORP (BTMD) · Seres Therapeutics Inc (MCRB) · Neonc Technologies HLDGS (NTHI)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-29.